Showing 1–7 of 7 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Rebecca Thomas, Nicola L Harman, Paula R Williamson, Laura Bonnett, Geraint R Davies, et al.
**BACKGROUND:** The global burden of tuberculosis (TB) remains high, and treatment of both drug-susceptible and drug-resistant diseases is complex and prolonged. International clinical trial networks and public-private partnerships are beginning to deliver advances in TB treatmen…
Janmejaya Samal, Ranjit Kumar Dehury, M Benson Thomas, Hari Singh
…fe, low medication adherence, progression to drug-resistant tuberculosis, and ultimately, mortality. **OBJECTIVES:** This study aimed to estimate the pooled prevalence of depression in TB patients and identify the predictors of depression in this population in India. **METHODS:…
Heda Melinda Nataprawira, Intan M W Dewi, I Gusti Agung Ayu Novi Wiraningrat, Citra Cesilia
**INTRODUCTION:** Post-tuberculosis lung disease (PTLD) causes health problems among pulmonary TB (PTB) survivors. Post-TB patients may suffer from chronic respiratory symptoms, declining lung function, and persistent radiological abnormalities. However, studies regarding PTLD in…
Zhen Feng, Hailan Wu, Qian Li, Xiaoqiang Zhang, Qingfeng He, et al.
…n (HDR) regimens have demonstrated significant potential in tuberculosis (TB) treatment. This study aims to evaluate the efficacy and safety profile of different HDR regimens. **DESIGN:** Using a systematic review and Bayesian network meta-analysis (NMA). **DATA SOURCES:** PubM…
Agathe Béranger, Belén P Solans, Ryo Miyakawa, Helen McIlleron, Joel Tarning, et al.
…UND:** Isoniazid is a cornerstone of management therapy for tuberculosis (TB). Our aim was to determine the association between isoniazid exposure and clinical outcomes, to develop a pharmacokinetic model, and to optimise the dosing regimen in children treated for drug-susceptibl…
Tae Kyu Chung, Eunsol Yang, Maureen Shin, Belen P Solans, Xujia Zhou, et al.
**BACKGROUND:** Tuberculosis affects over a million children annually. Ethambutol (EMB) is a key component of the standard four-drug therapy for drug-susceptible tuberculosis in children, yet comprehensive pharmacokinetic studies have been lacking. We characterized the population…
Hemant Deepak Shewade, Prabhadevi Ravichandran, S Satish, S Kiran Pradeep, Kathiresan Jeyashree, et al.
…glycemic agents (OHAs) has been recommended for people with tuberculosis and diabetes mellitus (TB-DM). This systematic review (PROSPERO 2016:CRD42016039101) analyses whether this improves TB treatment outcomes. This is an updated review (up to August 2024) of a previously publis…